Stereotactic body radiation therapy (SBRT) is an advanced technique of external beam radiation therapy that delivers large ablative doses of radiation. In the past decade, many cancer centers have adopted SBRT as one mode of radically treating small-sized hepatocellular carcinoma (HCC), based on encouraging clinical outcomes. SBRT thus seems reasonable as first-line treatment of inoperable HCC confined to the liver. However, most of the clinical studies to date have been retrospective in nature, with key issues still under investigation.
小肝癌立体定向放射治疗亚太共识
发布日期:2017-08-30
英文标题:Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting
来源:Liver Cancer, 2017, 6(4): 264-274
阅读次数:788
相关指南
- 2016年台湾共识指南:肝细胞癌的管理(更新版)
- 2017年中国专家共识:肝血管瘤射频消融治疗(英文版)
- NCCN临床实践指南:肝胆肿瘤(2017.V4)
- 原发性肝癌诊疗规范(2017年版)解读
- 肝细胞癌切除术后复发转移的防治:华西医院多学科专家共识
- 小肝癌立体定向放射治疗亚太共识
- 影像引导肝脏肿瘤热消融治疗技术临床规范化应用专家共识
- NCCN临床实践指南:肝胆肿瘤(2017.V3)
- 亚太肝细胞癌管理临床实践指南推荐意见(2017年更新版)
- 《2016年韩国腹部影像学会共识推荐:钆酸增强MRI诊断肝细胞癌》摘译
- 《2017年美国国立癌症综合网络肝胆肿瘤临床实践指南(V2版)》更新要点及临床路径